Monogram Technologies Inc. Overview
Pro stress-test →Monogram Technologies develops surgical robots to enable placement of patient-optimized orthopedic implants, and was acquired by Zimmer Biomet Holdings as of October 7, 2025. The company revolutionizes orthopedic joint replacement surgery with its mBôs robotic technology that links 3D printing and robotics with advanced pre-operative imaging.
Strategic Profile
Pro stress-test →The company's vision is to combine a surgical robot that addresses economic and clinical pain points with personalized implants, moving away from the generic "one size fits none" model that is too costly. A historic milestone was achieved with the world's first fully autonomous saw-based robotic knee replacement surgery on a live patient on July 26, 2025, at Krishna Shalby Hospital in Ahmedabad, India.
Competitive Landscape
Pro stress-test →The company takes a similar approach to Mako in robotic orthopedic surgery. Main competitors include Stryker (Mako Surgical Systems), Johnson & Johnson (Orthotaxy), and Smith+Nephew in robotic-assisted joint replacement. Monogram differentiates through autonomous surgical capabilities, 3D-printed custom implants, and reduced operative time targeting.
Industry Context
Monogram Technologies Inc. operates in Medical Devices - Surgical Robotics & Orthopedic Implants.
Key facts
Founded: 2015 · Headquarters: Austin, Texas · Market cap: $177M (acquisition value)